Concepedia

Melanie Blank

MB

9

Publications

974

Citations

9

H-Index

2000

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

Roche (Switzerland)

Mayo Clinic

United States Food and Drug Administration

Boehringer Ingelheim (United States)

Melanie Blank is an author at Center for Drug Evaluation and Research specializing in medicine, urology, and nephrology.

ORCID

Top concepts

Publications per year

2000–2020

9

Publications

9

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium

Frank Dieterle, Frank D. Sistare, Federico Goodsaid et al. · Nature Biotechnology · 2010 · 403 citations

, , +9

Erythropoiesis-Stimulating Agents — Time for a Reevaluation

Ellis F. Unger, Aliza M. Thompson, Melanie Blank et al. · New England Journal of Medicine · 2010 · 247 citations

Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy

Aliza Thompson, Daniel Cattran, Melanie Blank et al. · Journal of the American Society of Nephrology · 2015 · 94 citations · Full text

, , +17

End Points for Clinical Trials in Primary Hyperoxaluria

Dawn S. Milliner, Tracy L. McGregor, Aliza Thompson et al. · Clinical Journal of the American Society of Nephrology · 2020 · 80 citations · Full text

Reliability of causes of death in persons with Type I diabetes

I. M x FC hlhauser, P. T. Sawicki, Melanie Blank et al. · Diabetologia · 2002 · 56 citations · Full text

, , +7

Rows per page

1–5 of 9